Ann: Investor Presentation - March 2017, page-36

Hey Cuppa, don't be too quick to criticize Winner. He's entitled to a view, and in the main I agree with him and I'm a substantial holder. There is no doubt that this company has all the hallmarks of being a leader in the MM market, they have everything going for them if you believe what they put out in their reports, their direction, reading the opportunities etc etc, but...I have some reservations and so does the market obviously (which id why I don't have any particular sentiment)
Looking at comparative data since 21st Feb AC8 has increased in SP by approx 325%, CPH by 240% MMJ by 176% and MXC by 84%. As a result of the CR there was an effective dilution of around 15% so effectively you could say that this was equivalent to around an undiluted growth of approx. 96%. Even with the CR MXC for all its "promise" is well behind ...Why?